Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
GNMK GenMark Diagnostics, Inc. daily Stock Chart
GNMK [NASD]
GenMark Diagnostics, Inc.
Healthcare | Medical Devices | USA
statements
Index- P/E- EPS (ttm)-0.56 Insider Own4.30% Shs Outstand66.53M Perf Week2.89%
Market Cap818.40M Forward P/E- EPS next Y-0.12 Insider Trans-12.68% Shs Float55.50M Perf Month-13.99%
Income-33.70M PEG- EPS next Q-0.06 Inst Own99.10% Short Float12.64% Perf Quarter-31.30%
Sales126.90M P/S6.45 EPS this Y9.40% Inst Trans1.63% Short Ratio6.10 Perf Half Y-6.30%
Book/sh1.36 P/B8.63 EPS next Y53.80% ROA-26.80% Target Price- Perf Year97.64%
Cash/sh1.91 P/C6.16 EPS next 5Y- ROE-108.60% 52W Range3.36 - 20.88 Perf YTD144.07%
Dividend- P/FCF- EPS past 5Y2.30% ROI-51.50% 52W High-44.54% Beta3.17
Dividend %- Quick Ratio5.20 Sales past 5Y23.50% Gross Margin37.90% 52W Low244.64% ATR0.84
Employees437 Current Ratio5.70 Sales Q/Q117.90% Oper. Margin-21.10% RSI (14)41.35 Volatility5.53% 6.91%
OptionableYes Debt/Eq0.78 EPS Q/Q69.80% Profit Margin-26.50% Rel Volume1.05 Prev Close11.74
ShortableYes LT Debt/Eq0.78 EarningsOct 28 AMC Payout- Avg Volume1.15M Price11.58
Recom1.90 SMA20-8.83% SMA50-11.50% SMA2009.83% Volume1,204,977 Change-1.36%
Aug-05-20Reiterated Needham Buy $19 → $22
Jul-08-20Reiterated Needham Buy $15 → $19
May-05-20Reiterated Needham Buy $11 → $15
Feb-11-20Downgrade Raymond James Outperform → Mkt Perform
Dec-11-19Downgrade JP Morgan Overweight → Neutral
Feb-22-19Reiterated Needham Buy $12
Nov-03-17Reiterated Needham Buy $15 → $11
Nov-03-17Downgrade Raymond James Outperform → Mkt Perform
Sep-18-17Initiated BofA/Merrill Buy $13
Sep-13-17Reiterated Needham Buy $17 → $15
Aug-31-17Resumed BTIG Research Buy $13
Jun-13-17Reiterated Needham Buy $16 → $17
Jan-24-17Reiterated Needham Buy $13 → $15
Feb-24-16Reiterated Needham Buy $13 → $11
Oct-28-15Reiterated Needham Buy $16 → $13
May-06-15Reiterated Canaccord Genuity Buy $16 → $14
Apr-17-15Reiterated Canaccord Genuity Buy $17 → $16
Dec-19-13Initiated Needham Buy $17
Aug-08-13Reiterated Canaccord Genuity Buy $18 → $14
Apr-15-13Reiterated Canaccord Genuity Buy $14 → $18
Oct-28-20 04:05PM  
GenMark Diagnostics Reports Third Quarter 2020 Results
GlobeNewswire
02:30PM  
GenMark Diagnostics, Inc. to Host Earnings Call
ACCESSWIRE
Oct-21-20 12:32PM  
GenMark Diagnostics (GNMK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Zacks
Oct-14-20 05:20PM  
GenMark Diagnostics to Report Third Quarter 2020 Financial Results on October 28, 2020
GlobeNewswire
Oct-09-20 09:59AM  
Dow Jones Today, Stocks Climb Toward October Surprise; Deal Chatter Ignites Xilinx
Investor's Business Daily
04:37AM  
GenMark Pops 13% On Very Strong 3Q, FDA Emergency Clearance
SmarterAnalyst
Oct-08-20 04:05PM  
GenMark Diagnostics ePlex® Respiratory Pathogen Panel 2 (RP2) Receives EUA from FDA
GlobeNewswire -5.36%
04:03PM  
GenMark Diagnostics Provides Preliminary Financial Results for Third Quarter 2020
GlobeNewswire
Sep-29-20 10:50AM  
Hedge Funds Are Still Plowing Into GenMark Diagnostics, Inc (GNMK)
Insider Monkey
Sep-22-20 07:00AM  
Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments
PR Newswire
Sep-16-20 10:08AM  
Are Options Traders Betting on a Big Move in GenMark Diagnostics (GNMK) Stock?
Zacks
Sep-14-20 04:05PM  
GenMark Diagnostics ePlex® Respiratory Pathogen Panel 2 (RP2) achieves CE Mark
GlobeNewswire
Sep-07-20 01:53PM  
Breakeven On The Horizon For GenMark Diagnostics, Inc. (NASDAQ:GNMK)
Simply Wall St.
Aug-27-20 12:39PM  
Why Co-Diagnostics, GenMark, Luminex, and Opko Stocks Are Sinking Today
Motley Fool -12.77%
Aug-17-20 08:00AM  
GenMark Diagnostics Announces Submission of Emergency Use Authorization for its eSensor® SARS-CoV-2 Test
GlobeNewswire
Aug-05-20 02:01AM  
GenMark Diagnostics Inc (GNMK) Q2 2020 Earnings Call Transcript
Motley Fool
Aug-04-20 05:20PM  
Recap: GenMark Diagnostics Q2 Earnings
Benzinga
04:05PM  
GenMark Diagnostics Reports Second Quarter 2020 Results
GlobeNewswire
Jul-29-20 04:05PM  
GenMark Diagnostics to Participate in Upcoming Investor Conferences
GlobeNewswire
Jul-24-20 10:15AM  
Why A Covid-19 Vaccine Won't Halt Feverish Demand For Coronavirus Tests
Investor's Business Daily -6.30%
Jul-22-20 12:22PM  
Is GenMark Diagnostics' (NASDAQ:GNMK) Share Price Gain Of 186% Well Earned?
Simply Wall St.
11:30AM  
Has GenMark Diagnostics (GNMK) Outpaced Other Medical Stocks This Year?
Zacks
Jul-21-20 04:05PM  
GenMark Diagnostics to Report Second Quarter 2020 Financial Results on August 4, 2020
GlobeNewswire
04:05PM  
GenMark Diagnostics to Report Second Quarter 2020 Financial Results on August 4, 2020
GlobeNewswire
Jul-14-20 06:56AM  
GenMark's Shares March Higher, Can It Continue?
Zacks
Jul-09-20 09:54PM  
GenMark Diagnostics (GNMK) Stock Is a Winner, But How Much Higher Can It Go?
SmarterAnalyst
Jul-08-20 04:18PM  
Covid Report: Coronavirus Test Maker GenMark Diagnostics Jumps On Sales Beat
Investor's Business Daily +20.97%
12:07PM  
Why GenMark Diagnostics Stock Is Soaring Today
Motley Fool
07:31AM  
The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy
Benzinga
04:55AM  
GenMark Soaring In Pre-Market On 118% Revenue Explosion
SmarterAnalyst
Jul-07-20 04:05PM  
GenMark Diagnostics Provides Preliminary Financial and Operational Results for Second Quarter 2020
GlobeNewswire
Jun-29-20 07:00AM  
GenMark Diagnostics Announces Commercial Launch of its ePlex® Respiratory Pathogen Panel 2 (RP2)
GlobeNewswire
Jun-28-20 04:07PM  
Hedge Funds Cashing Out Of GenMark Diagnostics, Inc (GNMK)
Insider Monkey
Jun-27-20 01:15PM  
Heres a hedge fund strategy that just might work for you
MarketWatch
Jun-19-20 12:16PM  
Will GenMark Diagnostics Continue to Surge Higher?
Zacks +6.34%
12:00PM  
GenMark Diagnostics (GNMK) Upgraded to Strong Buy: Here's What You Should Know
Zacks
Jun-16-20 08:00AM  
GenMark Diagnostics Chosen as Primary Provider of Rapid Diagnostic Testing for Vidant Health
GlobeNewswire
Jun-12-20 07:55PM  
Edited Transcript of GNMK earnings conference call or presentation 4-May-20 8:30pm GMT
Thomson Reuters StreetEvents +6.04%
Jun-10-20 08:35AM  
Soliton (SOLY) Catches Eye: Stock Jumps 5.2%
Zacks +6.85%
08:29AM  
TransEnterix (TRXC) Catches Eye: Stock Jumps 6.3%
Zacks
May-28-20 10:30AM  
GenMark Diagnostics Sees Hammer Chart Pattern: Time to Buy?
Zacks
May-27-20 04:05PM  
GenMark Diagnostics to Participate in Upcoming Investor Conferences
GlobeNewswire
May-26-20 08:49AM  
Is GenMark Diagnostics (GNMK) Stock a Solid Choice Right Now?
Zacks
May-14-20 11:16AM  
Will GenMark Diagnostics' Stock Keep Rising?
Motley Fool
May-11-20 04:01PM  
GenMark Diagnostics Announces Closing of $80 Million Public Offering of Common Stock, Including Full Exercise of Underwriters Option to Purchase Additional Shares
GlobeNewswire +6.27%
May-08-20 10:52AM  
Top Ranked Momentum Stocks to Buy for May 8th
Zacks -6.85%
May-07-20 10:39AM  
GenMark Diagnostics: P/E Ratio Insights
Benzinga +32.23%
May-06-20 10:59PM  
GenMark Prices Public Offering of Common Stock
GlobeNewswire -14.64%
04:01PM  
GenMark Commences Public Offering of Common Stock
GlobeNewswire
May-05-20 08:00AM  
The Daily Biotech Pulse: Bio-Rad's Coronavirus Test Gets EUA, Beat-And-Raise Quarter From GenMark, Adverum's Positive Gene Therapy Readout
Benzinga
04:01AM  
GenMark Diagnostics Inc (GNMK) Q1 2020 Earnings Call Transcript
Motley Fool
May-04-20 06:55PM  
GenMark Diagnostics (GNMK) Reports Q1 Loss, Tops Revenue Estimates
Zacks -6.83%
04:05PM  
GenMark Diagnostics Reports First Quarter 2020 Results
GlobeNewswire
04:03PM  
GenMark Diagnostics Announces Scott Mendel Appointed CEO
GlobeNewswire
Apr-27-20 12:31PM  
GenMark Diagnostics (GNMK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Zacks
Apr-24-20 10:50AM  
3 Monster Growth Stocks Gearing up for Gains
TipRanks +5.40%
Apr-23-20 10:01AM  
Implied Volatility Surging for GenMark (GNMK) Stock Options
Zacks +18.34%
Apr-22-20 04:05PM  
GenMark Diagnostics to Report First Quarter 2020 Financial Results on May 4, 2020
GlobeNewswire +6.26%
Apr-20-20 07:54AM  
A Look At The Fair Value Of GenMark Diagnostics, Inc. (NASDAQ:GNMK)
Simply Wall St. +6.72%
Apr-08-20 04:26PM  
Covid Report: Small Biotech Surges On Plan To Test Vaccine In May
Investor's Business Daily +34.22%
07:53AM  
The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO
Benzinga
02:45AM  
GenMark Sees 80% Q1 Revenue Boost on Covid-19 Tests
SmarterAnalyst
Apr-07-20 04:03PM  
GenMark Diagnostics Provides Preliminary Financial and Operational Results for First Quarter 2020 and Increases 2020 Revenue Guidance
GlobeNewswire
Mar-23-20 07:45PM  
GenMark Awarded BARDA Grant for the Development of ePlex® RP2 Panel
GlobeNewswire -20.90%
09:31AM  
Is the Options Market Predicting a Spike in GenMark (GNMK) Stock?
Zacks
09:30AM  
Company News for Mar 23, 2020
Zacks
Mar-22-20 08:19AM  
3 Coronavirus Stocks with Over 60% Upside
TipRanks
Mar-19-20 09:23PM  
GenMark Receives FDA Emergency Use Authorization for its ePlex® SARS-CoV-2 Test
GlobeNewswire +16.01%
Mar-11-20 12:47PM  
Edited Transcript of GNMK earnings conference call or presentation 2-Mar-20 9:30pm GMT
Thomson Reuters StreetEvents +14.11%
10:44AM  
GenMark's stock rises 8% as it seeks authorization to market its COVID-19 test
MarketWatch
10:18AM  
GenMark Diagnostics Submits Test for Coronavirus to FDA
TheStreet.com
09:54AM  
The Zacks Analyst Blog Highlights: Co-Diagnostics, GenMark Diagnostics, OPKO Health and Inovio Pharmaceuticals
Zacks
09:06AM  
GenMark Diagnostics Files For Emergency Use Authorization For COVID-19 Test
Benzinga
08:26AM  
Benzinga Pro's Top 5 Stocks To Watch For Wed., Mar. 11, 2020: TDOC, GNMK, HLT, MEET, AYTU
Benzinga
08:00AM  
GenMark Diagnostics Announces Submission of Emergency Use Authorization for its ePlex® SARS-CoV-2 Test
GlobeNewswire
Mar-04-20 08:04AM  
Benzinga Pro's Top 5 Stocks To Watch For Wed., Mar. 4, 2020: JWN, VIR, CMG, AHPI, GNMK
Benzinga +6.65%
Mar-02-20 05:35PM  
GenMark Diagnostics (GNMK) Reports Q4 Loss, Tops Revenue Estimates
Zacks
04:05PM  
GenMark Diagnostics Reports Fourth Quarter and Full Year 2019 Results
GlobeNewswire
04:03PM  
GenMark Diagnostics Announces Global Shipments of ePlex® RUO Test Kits Designed for SARS-CoV-2 Detection
GlobeNewswire
Feb-25-20 08:35AM  
Zacks.com featured highlights include: Calavo Growers, eBay, GenMark Diagnostics, Telenav and Heico
Zacks
Feb-24-20 12:30PM  
GenMark Diagnostics (GNMK) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks -6.13%
09:28AM  
Go Beyond Bargain Hunting: 5 Stocks With Rising P/E
Zacks
Feb-18-20 04:05PM  
GenMark Diagnostics to Participate in the Cowen Health Care Conference
GlobeNewswire
Feb-17-20 05:57AM  
GenMark Diagnostics Enters Oversold Territory
Zacks
Feb-10-20 05:30PM  
GenMark Diagnostics Schedules Fourth Quarter and Full Year 2019 Financial Results Conference Call for March 2, 2020
GlobeNewswire
05:15PM  
GenMark Diagnostics Announces CEO and Chairman Transition
GlobeNewswire
Jan-13-20 07:00AM  
GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2019
GlobeNewswire -5.92%
Jan-06-20 07:25AM  
Investors Who Bought GenMark Diagnostics (NASDAQ:GNMK) Shares Five Years Ago Are Now Down 64%
Simply Wall St.
Jan-01-20 12:14PM  
Penny Stocks to Buy Using Technical Analysis for January 2020
Investopedia
Dec-31-19 07:57AM  
Penny Stocks to Watch for January 2020
Investopedia
Dec-30-19 04:05PM  
GenMark Diagnostics to Participate in the J.P. Morgan Healthcare Conference
GlobeNewswire
Dec-12-19 09:07PM  
Edited Transcript of GNMK earnings conference call or presentation 6-Nov-19 9:30pm GMT
Thomson Reuters StreetEvents
07:38PM  
Hedge Funds Have Never Been This Bullish On GenMark Diagnostics, Inc (GNMK)
Insider Monkey
Nov-13-19 04:05PM  
GenMark Diagnostics to Participate in Upcoming Investor Conferences
GlobeNewswire
Nov-07-19 07:22AM  
Why GenMark Diagnostics, Inc. (NASDAQ:GNMK) Could Be Worth Watching
Simply Wall St.
Nov-06-19 06:45PM  
GenMark Diagnostics (GNMK) Reports Q3 Loss, Tops Revenue Estimates
Zacks
04:03PM  
GenMark Diagnostics Reports Third Quarter 2019 Results
GlobeNewswire
Nov-01-19 12:15PM  
Hedge Funds Have Never Been More Bullish On GenMark Diagnostics, Inc (GNMK)
Insider Monkey
Oct-30-19 10:34AM  
GenMark Diagnostics (GNMK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Zacks
Oct-23-19 04:05PM  
GenMark Diagnostics Schedules Third Quarter 2019 Financial Results Conference Call for November 6, 2019
GlobeNewswire
GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular panels based on its proprietary eSensor electrochemical detection technology. It provides ePlex instrument and respiratory pathogen panel, which integrates automated nucleic acid extraction and amplification with its eSensor technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results. The company offers XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents to support a range of molecular tests with a workstation and disposable test cartridges. It also provides diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, thrombophilia risk test, a warfarin sensitivity test, and hepatitis C virus genotyping test and associated custom manufactured reagents, as well as 2C19 genotyping test. The company sells its products through direct sales and technically specialized service organization in the United States and Europe. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jensen TylerSVP, Engineering and Tech DevOct 15Sale11.835005,915209,765Oct 16 05:01 PM
Maderazo Alan BaerVP, Qual, Reg, & Clin AffairsOct 07Option Exercise12.7658,680748,786319,870Oct 09 06:35 PM
Maderazo Alan BaerVP, Qual, Reg, & Clin AffairsOct 07Sale15.0069,7491,046,235250,121Oct 09 06:35 PM
Jensen TylerSVP, Engineering and Tech DevOct 01Sale14.465007,230210,265Oct 02 07:37 PM
Ek John FrederickChief Financial OfficerSep 22Sale13.8241,196569,329181,339Sep 24 05:58 PM
Jensen TylerSVP, Engineering and Tech DevSep 17Sale12.725006,360210,765Sep 18 05:39 PM
Ek John FrederickChief Financial OfficerSep 16Sale12.985,72374,285222,535Sep 18 05:40 PM
Mitchell Brian AndrewSVP, OperationsSep 08Sale11.024,00044,080166,651Sep 10 05:45 PM
Shaw ChristineVP, Assay DevelopmentSep 08Sale11.022853,14179,714Sep 10 06:14 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesSep 08Sale11.027708,485137,212Sep 10 06:16 PM
Jensen TylerSVP, Engineering and Tech DevSep 03Sale12.205006,100211,265Sep 04 05:44 PM
Maderazo Alan BaerVP, Qual, Reg, & Clin AffairsAug 27Sale13.1089111,672261,190Aug 28 05:54 PM
Mendel ScottPresident & CEOAug 26Sale15.0250,000751,00081,690Aug 28 05:53 PM
Mitchell Brian AndrewSVP, OperationsAug 26Sale14.743,46451,059170,651Aug 26 06:32 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesAug 25Sale14.141,22317,293137,982Aug 26 06:14 PM
Gleeson MichaelSVP, Corp. AccountsAug 25Sale14.142,90441,063352,040Aug 26 06:15 PM
Shaw ChristineVP, Assay DevelopmentAug 25Sale14.143795,35979,999Aug 26 06:17 PM
Ek John FrederickChief Financial OfficerAug 25Sale14.141,51521,422228,258Aug 26 06:18 PM
Jensen TylerSVP, Engineering and Tech DevAug 25Sale14.141,21117,124211,765Aug 26 06:27 PM
Maderazo Alan BaerVP, Qual, Reg, & Clin AffairsAug 25Sale14.142,13030,118262,081Aug 26 06:28 PM
Stier EricSVP & General CounselAug 25Sale14.142,68437,952293,397Aug 26 06:29 PM
Mendel ScottPresident & CEOAug 25Sale14.144,53264,082489,808Aug 26 06:30 PM
Mitchell Brian AndrewSVP, OperationsAug 25Sale14.142,08329,454174,115Aug 26 06:32 PM
Mitchell Brian AndrewSVP, OperationsAug 21Sale15.622,99746,813176,198Aug 24 06:11 PM
Gleeson MichaelSVP, Corp. AccountsAug 20Sale15.411,69126,058354,944Aug 24 07:37 PM
Ek John FrederickChief Financial OfficerAug 20Sale15.602,59140,431229,773Aug 24 06:07 PM
Jensen TylerSVP, Engineering and Tech DevAug 20Sale15.411,18418,245212,976Aug 24 06:07 PM
Stier EricSVP & General CounselAug 20Sale15.411,60624,748296,081Aug 24 06:08 PM
Winkler Sarah HollisVP, Human ResourcesAug 20Sale15.4167710,433125,597Aug 24 06:10 PM
Mitchell Brian AndrewSVP, OperationsAug 20Sale15.411,69126,058179,195Aug 24 06:11 PM
Maderazo Alan BaerVP, Qual, Reg, & Clin AffairsAug 20Sale15.411,35320,850264,211Aug 24 06:12 PM
Mendel ScottPresident & CEOAug 20Sale15.412,98846,045494,340Aug 24 06:13 PM
Mitchell Brian AndrewSVP, OperationsAug 19Sale15.5244,881696,553180,886Aug 20 06:15 PM
Ek John FrederickChief Financial OfficerAug 18Sale15.9828,307452,346232,364Aug 18 06:09 PM
Mitchell Brian AndrewSVP, OperationsAug 18Sale15.854206,657225,767Aug 20 06:15 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesAug 17Sale15.3836,570562,447139,205Aug 18 06:15 PM
Ek John FrederickChief Financial OfficerAug 14Sale15.975,07080,968260,671Aug 18 06:09 PM
Mendel ScottPresident & CEOAug 12Sale15.0850,000754,000131,690Aug 14 06:06 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesAug 04Sale18.932083,937175,775Aug 05 07:25 PM
Mitchell Brian AndrewSVP, OperationsAug 04Sale18.9362111,756226,187Aug 05 07:23 PM
Mitchell Brian AndrewSVP, OperationsAug 03Sale17.924,00071,680226,808Aug 03 06:39 PM
Jensen TylerSVP, Engineering and Tech DevJul 28Sale17.302123,668214,160Jul 29 07:09 PM
Harkins Michael JohnSVP, SalesJul 28Sale17.301,05218,200131,074Jul 29 07:03 PM
Winkler Sarah HollisVP, Human ResourcesJul 28Sale17.3073712,750126,274Jul 29 07:01 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesJul 28Sale17.301702,941175,983Jul 29 06:59 PM
Mitchell Brian AndrewSVP, OperationsJul 01Sale14.454,00057,800230,808Jul 02 06:28 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesJun 08Sale9.147807,129176,153Jun 09 05:37 PM
Mitchell Brian AndrewSVP, OperationsJun 01Sale9.724,00038,880234,808Jun 02 06:04 PM
Mitchell Brian AndrewSVP, OperationsMay 28Sale9.522,02119,240238,808Jun 01 05:19 PM
Ek John FrederickChief Financial OfficerMay 28Sale9.521,46013,899265,741Jun 01 05:15 PM
Jensen TylerSVP, Engineering and Tech DevMay 28Sale9.521,16811,119214,372Jun 01 05:13 PM
Maderazo Alan BaerVP, Qual, Reg, & Clin AffairsMay 28Sale9.522,06619,668265,564Jun 01 05:11 PM
Mendel ScottPresident & CEOMay 28Sale9.523,75135,710447,328Jun 01 05:08 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesMay 28Sale9.521,17911,224176,933Jun 01 05:05 PM
Stier EricSVP & General CounselMay 28Sale9.522,60224,771297,687Jun 01 05:03 PM
Gleeson MichaelSVP, Corp. AccountsMay 28Sale9.522,81526,799433,127Jun 01 04:59 PM
Maderazo Alan BaerVP, Qual, Reg, & Clin AffaiirsMay 19Sale10.461,31913,797267,630May 20 06:12 PM
Mitchell Brian AndrewSVP, OperationsMay 19Sale10.462,13122,290240,829May 20 06:10 PM
Jensen TylerSVP, Engineering and Tech DevMay 19Sale10.461,15412,071215,540May 20 06:06 PM
Mendel ScottPresident & CEOMay 19Sale10.462,80029,288451,079May 20 06:02 PM
Ek John FrederickChief Financial OfficerMay 19Sale10.461,64817,238267,201May 20 06:00 PM
Stier EricSVP & General CounselMay 19Sale10.461,56616,380300,289May 20 05:59 PM
Winkler Sarah HollisVP, Human ResourcesMay 19Sale10.466616,914127,011May 20 05:57 PM
Gleeson MichaelSVP, Corp. AccountsMay 19Sale10.461,64817,238435,942May 20 05:56 PM
Gleeson MichaelSVP, Corp. AccountsMay 07Option Exercise6.4956,816368,736466,308May 08 05:07 PM
Mitchell Brian AndrewSVP, OperationsMay 05Sale13.497039,483242,960May 06 05:29 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesMay 05Sale13.492363,184178,112May 06 05:27 PM
Mitchell Brian AndrewSVP, OperationsMay 01Sale12.444,00049,760243,663May 04 05:10 PM
FAULKNER DARYLDirectorApr 29Option Exercise6.0014,45086,700120,238May 01 06:08 PM
Harkins Michael JohnSVP, SalesApr 29Sale11.644,12448,003132,126May 01 06:12 PM
Jensen TylerSVP, Engineering and Tech DevApr 29Sale11.648309,661216,694May 01 06:06 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesApr 29Sale11.641681,956178,348May 01 06:05 PM
Winkler Sarah HollisVP, Human ResourcesApr 29Sale11.647268,451127,672May 01 06:02 PM
Mitchell Brian AndrewSVP, OperationsApr 20Sale8.008,00064,000247,663Apr 21 05:19 PM
Mitchell Brian AndrewSVP, OperationsApr 01Sale3.992,0007,980255,663Apr 03 05:10 PM
Fox JamesDirectorMar 06Buy5.509,00049,50081,085Mar 10 11:44 AM
OBOYLE KEVIN CDirectorMar 06Buy4.5310,80048,924103,550Mar 09 11:22 AM
Kagnoff MichaelDirectorMar 04Buy4.6110,00046,100118,216Mar 05 11:44 AM
Mitchell Brian AndrewSVP, OperationsMar 02Sale3.502,0007,000257,663Mar 03 05:28 PM
Mitchell Brian AndrewSVP, OperationsFeb 27Sale3.511,9876,974259,663Feb 28 05:48 PM
Mendel ScottInterim President & CEOFeb 27Sale3.512,6599,333547,111Feb 28 05:50 PM
Ek John FrederickChief Financial OfficerFeb 27Sale3.511,0403,650268,849Feb 28 05:44 PM
Gleeson MichaelSVP, Corp. AccountsFeb 27Sale3.511,9967,006409,492Feb 28 05:46 PM
Jensen TylerSVP, Engineering and Tech DevFeb 27Sale3.519733,415217,524Feb 28 05:47 PM
Stier EricSVP & General CounselFeb 27Sale3.511,8066,339301,855Feb 28 05:44 PM
Gleeson MichaelSVP, Corp. AccountsFeb 25Sale3.811,0534,012411,488Feb 27 08:59 PM
Jensen TylerSVP, Engineering and Tech DevFeb 25Sale3.813811,452218,497Feb 27 08:58 PM
Stier EricSVP & General CounselFeb 25Sale3.819853,753303,661Feb 27 08:56 PM
Mendel ScottInterim President & CEOFeb 25Sale3.811,4025,342549,770Feb 27 08:54 PM
Mitchell Brian AndrewSVP, OperationsFeb 25Sale3.81232884261,650Feb 27 08:53 PM
Ek John FrederickChief Financial OfficerFeb 25Sale3.815161,966269,889Feb 27 08:50 PM
Gleeson MichaelSVP, Corp. AccountsFeb 20Sale3.809,70136,864326,291Feb 21 05:26 PM
Jensen TylerSVP, Engineering and Tech DevFeb 20Sale3.806,31824,008128,878Feb 21 05:19 PM
Mendel ScottInterim President & CEOFeb 20Sale3.8014,53655,237326,172Feb 21 05:17 PM
Stier EricSVP & General CounselFeb 20Sale3.809,34835,522225,896Feb 21 05:16 PM
Ek John FrederickChief Financial OfficerFeb 20Sale3.808,84833,622165,405Feb 21 05:12 PM
Mitchell Brian AndrewSVP, OperationsFeb 20Sale3.808,15530,989194,382Feb 21 05:09 PM
Winkler Sarah HollisVP, Human ResourcesFeb 20Sale3.803,38712,87153,398Feb 21 05:08 PM
Mitchell Brian AndrewSVP, OperationsFeb 04Sale5.407804,212202,537Feb 05 05:49 PM
Mitchell Brian AndrewSVP, OperationsFeb 03Sale5.412,00010,820203,317Feb 04 06:05 PM
open in yahoo | open in reuters | open in google
affiliate | advertise | contact | privacy | help
Do not sell my personal information
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.